Osteoporosis drug new hope for Breast Cancer treatment

A new study, has found that a class of osteoporosis drugs called bi-sphosphonates may help to prevent breast cancer recurrence in older women. While many questions remain to be answered, the research suggests the drugs could soon become part of the standard of care for women with breast cancer, with the potential to save thousands of lives. Cancer doctors have suspected that these bone-strengthening drugs might help protect against the spread of breast cancer, but studies testing the theory have had mixed results.
"Our results show that adjuvant bi-sphosphonates in postmenopausal women prevent around a quarter of bone recurrences and one in six of all breast cancer deaths in the first decade of treatment," said Dr. Robert Coleman, a professor at the University of Sheffield in the U.K., and the lead author of the analysis. "These simple, well tolerated treatments should now be considered for routine use in the treatment of early breast cancer in women."